277 related articles for article (PubMed ID: 20181392)
1. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease.
Yanagisawa D; Shirai N; Amatsubo T; Taguchi H; Hirao K; Urushitani M; Morikawa S; Inubushi T; Kato M; Kato F; Morino K; Kimura H; Nakano I; Yoshida C; Okada T; Sano M; Wada Y; Wada KN; Yamamoto A; Tooyama I
Biomaterials; 2010 May; 31(14):4179-85. PubMed ID: 20181392
[TBL] [Abstract][Full Text] [Related]
2. Keto form of curcumin derivatives strongly binds to Aβ oligomers but not fibrils.
Yanagisawa D; Kato T; Taguchi H; Shirai N; Hirao K; Sogabe T; Tomiyama T; Gamo K; Hirahara Y; Kitada M; Tooyama I
Biomaterials; 2021 Mar; 270():120686. PubMed ID: 33540171
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
Ouberai M; Dumy P; Chierici S; Garcia J
Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
[TBL] [Abstract][Full Text] [Related]
4. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?
Narlawar R; Pickhardt M; Leuchtenberger S; Baumann K; Krause S; Dyrks T; Weggen S; Mandelkow E; Schmidt B
ChemMedChem; 2008 Jan; 3(1):165-72. PubMed ID: 17943713
[TBL] [Abstract][Full Text] [Related]
6. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
7. Curcumin tautomerization in the mechanism of pentameric amyloid- β42 oligomers disassembly.
Matsui A; Bellier JP; Hayashi D; Ishibe T; Nakamura Y; Taguchi H; Naruse N; Mera Y
Biochem Biophys Res Commun; 2023 Jul; 666():68-75. PubMed ID: 37178507
[TBL] [Abstract][Full Text] [Related]
8. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
9. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid beta protein-induced cytotoxicity.
Kwak JW; Kim HK; Chae CB
J Med Chem; 2006 Aug; 49(16):4813-7. PubMed ID: 16884292
[TBL] [Abstract][Full Text] [Related]
10. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
11. UV absorption and keto-enol tautomerism equilibrium of methoxy and dimethoxy 1,3-diphenylpropane-1,3-diones.
Zawadiak J; Mrzyczek M
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Feb; 75(2):925-9. PubMed ID: 20047853
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer's Disease.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Tomiyama T; Tooyama I
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806326
[TBL] [Abstract][Full Text] [Related]
13. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic dissociation and clearance of Alzheimer's beta-amyloid aggregates.
Lee JS; Park CB
Biomaterials; 2010 Sep; 31(26):6789-95. PubMed ID: 20542328
[TBL] [Abstract][Full Text] [Related]
15. Interaction between amyloid beta-protein aggregates and membranes.
Kakio A; Yano Y; Takai D; Kuroda Y; Matsumoto O; Kozutsumi Y; Matsuzaki K
J Pept Sci; 2004 Oct; 10(10):612-21. PubMed ID: 15526710
[TBL] [Abstract][Full Text] [Related]
16. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
17. The effect of curcumin on the stability of Aβ dimers.
Zhao LN; Chiu SW; Benoit J; Chew LY; Mu Y
J Phys Chem B; 2012 Jun; 116(25):7428-35. PubMed ID: 22690789
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
19. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
20. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
Karr JW; Szalai VA
Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
